US Patent 7973079 Methods and compounds for treating retinol-related diseases
Patent 7973079 was granted and assigned to ReVision Therapeutics on July, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 15, 2008
Date of Patent
July 5, 2011
Patent Application Number
12210802
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7973079 Methods and compounds for treating retinol-related diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
